Sanfer, officially known as Sanfer S.A. de C.V., is a prominent player in the pharmaceutical industry, headquartered in Mexico (MX). Established in 1985, the company has made significant strides in the development and distribution of high-quality pharmaceutical products across various therapeutic areas, including oncology, cardiology, and infectious diseases. With a strong operational presence in Latin America, Sanfer is recognised for its commitment to innovation and excellence in healthcare. The company offers a diverse portfolio of prescription medications and over-the-counter products, distinguished by their rigorous quality standards and advanced formulations. Sanfer's dedication to research and development has positioned it as a leader in the market, earning accolades for its contributions to public health and patient care. Through strategic partnerships and a focus on sustainability, Sanfer continues to enhance its impact within the pharmaceutical landscape.
How does Sanfer's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Metal Fabrication industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Sanfer's score of 7 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Sanfer reported total Scope 1 emissions of approximately 10,467,000 kg CO2e, comprising 9,267,000 kg CO2e from its Corporativo operations and 792,000 kg CO2e from its Salud Animal division. This represents a significant increase from 2022, where the total Scope 1 emissions were about 1,745,000 kg CO2e, with 985,000 kg CO2e from Aerobal and 760,000 kg CO2e from Salud Animal. Despite the increase in emissions, there are currently no publicly disclosed reduction targets or climate pledges from Sanfer. The company operates within the animal health and pharmaceutical sectors, which are increasingly scrutinised for their environmental impact. As such, Sanfer's commitment to addressing carbon emissions remains a critical area for future development.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sanfer is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.